Skip to main content
Top
Published in: Clinical and Translational Oncology 6/2013

01-06-2013 | Research Article

Is it necessary to dissect the lymph nodes around an abnormal hepatic artery in D2 lymphadenectomy for gastric cancer?

Authors: Y. Huang, C. Liu, J. L. Lin, G. C. Mu, Y. Zeng

Published in: Clinical and Translational Oncology | Issue 6/2013

Login to get access

Abstract

Background

Surgical resection remains the principal treatment for advanced gastric cancer. However, one of the difficulties in radical D2 lymphadenectomy is the identification of the vascular abnormalities around the stomach, especially abnormal hepatic artery. The hepatic artery arising from the superior mesenteric artery shows great variations, and whether or not the lymphatic tissues around the abnormal artery should be dissected is still controversial.

Method

Eighty-six gastric cancer patients who underwent radical D2 lymphadenectomy by the same surgeon in our department in the past 2 years were included in this study. All patients underwent multislice spiral computed tomography angiography for preoperative evaluation of the abnormal hepatic artery arising from the superior mesenteric artery. Postoperative immunohistochemistry of the lymphoid tissues around the abnormal hepatic artery was performed using CK20 and CEA antibodies to determine the occurrence of lymph node micrometastasis around the abnormal artery.

Results

In our study, we found 14 cases with an abnormal hepatic artery arising from the superior mesenteric artery. The hepatic artery ran in front of the pancreas in 1 case and behind the pancreas in 13 cases. Immunohistochemical analyses revealed no micrometastasis in the lymphoid tissues surrounding the abnormal artery.

Conclusions

Abnormal hepatic arteries arising from the superior mesenteric artery can be classified into pre-pancreas and post-pancreas types. Lymph nodes around the abnormal artery may not need to be dissected in radical D2 lymphadenectomy.
Literature
1.
go back to reference Malekzadeh R, Nasseri-Moghaddam S (2008) Reducing gastric cancer mortality in developing countries: learning from the experience in Japan. Arch Iran Med 11:588–590PubMed Malekzadeh R, Nasseri-Moghaddam S (2008) Reducing gastric cancer mortality in developing countries: learning from the experience in Japan. Arch Iran Med 11:588–590PubMed
2.
go back to reference Skoropad VIu, Berdov BA (2010) D2 lymphadenectomy for surgical and combined treatment of the gastric cancer. Khirurgiia (Mosk) 4:26–29 Skoropad VIu, Berdov BA (2010) D2 lymphadenectomy for surgical and combined treatment of the gastric cancer. Khirurgiia (Mosk) 4:26–29
3.
go back to reference Hartgrink HH, van de Velde CJ (2005) Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer. J Surg Oncol 90:153–165PubMedCrossRef Hartgrink HH, van de Velde CJ (2005) Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer. J Surg Oncol 90:153–165PubMedCrossRef
4.
go back to reference Balachandran A, Darden DL, Tamm EP (2008) Arterial variants in pancreatic adenocarcinoma. Abdom Imaging 33:214–221PubMedCrossRef Balachandran A, Darden DL, Tamm EP (2008) Arterial variants in pancreatic adenocarcinoma. Abdom Imaging 33:214–221PubMedCrossRef
5.
go back to reference JGCA: Japanese Gastric Cancer Association (2009) Gastric cancer treatment guidelines, 14th edn. Kanehara, Tokyo, pp 1–17 JGCA: Japanese Gastric Cancer Association (2009) Gastric cancer treatment guidelines, 14th edn. Kanehara, Tokyo, pp 1–17
6.
go back to reference Hiatt JR, Gabbay J, Busuttil RW (1994) Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg 220:50–52PubMedCrossRef Hiatt JR, Gabbay J, Busuttil RW (1994) Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg 220:50–52PubMedCrossRef
7.
go back to reference Maruyama K, Gunvén P et al (1989) Lymph node metastases of gastric cancer: general pattern in 1931 patients. Ann Surg 210(5):596–602PubMedCrossRef Maruyama K, Gunvén P et al (1989) Lymph node metastases of gastric cancer: general pattern in 1931 patients. Ann Surg 210(5):596–602PubMedCrossRef
8.
go back to reference Covey AM, Brody LA, Maluccio MA et al (2002) Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 224:542–547PubMedCrossRef Covey AM, Brody LA, Maluccio MA et al (2002) Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 224:542–547PubMedCrossRef
Metadata
Title
Is it necessary to dissect the lymph nodes around an abnormal hepatic artery in D2 lymphadenectomy for gastric cancer?
Authors
Y. Huang
C. Liu
J. L. Lin
G. C. Mu
Y. Zeng
Publication date
01-06-2013
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2013
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0955-3

Other articles of this Issue 6/2013

Clinical and Translational Oncology 6/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine